VIVA BIOTECH HOLDINGS revenue breakdown overview

VIVA BIOTECH HOLDINGS revenue for the last year amounted to 275.08 M EUR, the most of which — 168.00 M EUR — came from its highest performing source at the moment, Contract Development Manufacture Organisation and Commercialisation, the year earlier bringing 206.49 M EUR. The greatest contribution to the revenue figure was made by United States — last year it brought VIVA BIOTECH HOLDINGS 104.18 M EUR, and the year before that — 127.38 M EUR.